BH
Benjamin Hickey
President, RayzeBio Org.

Benjamin Hickey insider trades: Bristol Myers Squibb (BMY) stock sales

President, RayzeBio Org., Bristol Myers Squibb Last trade May 9, 2025 33 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
11
Open-market trades
since 2021
5
Companies
last trade 2025

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Benjamin reports to the SEC

Open-market buys and sales

11 trades reported on SEC Form 4, newest first

DateStockTypeValue
May 9, 2025BMY↓ Sell$4K
Jan 16, 2024MRTX↓ Sell$94K
Jan 8, 2024MRTX↓ Sell$123K
Dec 13, 2023MRTX↓ Sell$126K
Jan 17, 2023MRTX↓ Sell$66K
Jan 9, 2023MRTX↓ Sell$95K
Dec 21, 2022MRTX↓ Sell$131K
Jan 18, 2022MRTX↓ Sell$76K
Jan 7, 2022MRTX↓ Sell$267K
Mar 19, 2021MRTX↓ Sell$418K
Jan 7, 2021MRTX↓ Sell$450K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other BMY insiders

Open-market trades in the last 12 months

About Benjamin Hickey's insider trades

Benjamin Hickey is President, RayzeBio Org. at Bristol Myers Squibb (BMY). Since Jan 7, 2021, Benjamin has reported no open-market purchases and 11 sales worth $1.8M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (18 filings), option exercises (5 filings), shares withheld for taxes (4 filings), shares returned to the company (2 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BMY insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.